Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Core Points - Rigel Pharmaceuticals, Inc. has granted 79,890 stock options to eleven non-executive employees as part of its Inducement Plan approved by the Compensation Committee [1] - The stock options will vest over four years with a one-year cliff, which is a common structure in employee compensation plans [1] - This action is in accordance with NASDAQ Listing Rule 5635(c)(4), indicating compliance with regulatory requirements [4] Company Overview - Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing novel therapies for hematologic disorders and cancer [2] - The company was founded in 1996 and is headquartered in South San Francisco, California [2] - For more information on Rigel's marketed products and pipeline, the company provides resources on its website [2]